Loading chat...
PA SR122
Resolution
Status
6/6/2025
Primary Sponsor
Tracy Pennycuick
Click for details
AI Summary
-
Pennsylvania Senate urges U.S. Congress to pass H.R. 1947, the Treatment and Relief through Emerging and Accessible Therapy for PTSD Act, which would authorize stellate ganglion block (SGB) therapy for veterans and service members with PTSD
-
SGB involves injecting an anesthetic into neck nerves controlling the "fight or flight" reflex; the procedure has been used since the 1920s and was first recognized as a PTSD treatment in 2008
-
VA estimates 29% of Operation Enduring Freedom/Iraqi Freedom veterans, 21% of Persian Gulf War veterans, and 10% of Vietnam veterans have received PTSD diagnoses
-
Only 40% of veterans find relief from current PTSD treatments, and untreated PTSD contributes to approximately 20 veteran suicides per day in the U.S.
-
H.R. 1947 is supported by the Pennsylvania National Guard Associations, the American Legion, and behavioral health clinicians
Legislative Description
Urging the Congress of the United States to expand post-traumatic stress disorder treatment for veterans and service members by authorizing stellate ganglion block therapy through passage of H.R. 1947, the Treatment and Relief through Emerging and Accessible Therapy for PTSD Act.
Last Action
Referred to Veterans Affairs & Emergency Preparedness
6/6/2025